Delivery Order SPE2DB22D3016-SPE2DB24FBGU3
Award Date
9/13/24
Potential Completion Date
9/16/24
Potential Value
$29K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office Division. The $3,233.58 firm-fixed-price delivery order is for the supply of 4,565,699 units of the GARDASIL 9 vaccine syringe (0.5mL) with no set-aside designation. The contract has an ultimate completion date of September 6, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $7,442.58 firm fixed price delivery order is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product. The contract has an ultimate completion date of September 10, 2024. Amerisourcebergen holds a Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,320.14 firm fixed-price delivery order is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product. The contract has an ultimate completion date of April 4, 2025 and was awarded on April 3, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,274.75 firm-fixed-price delivery order is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product. The contract has an ultimate completion date of July 10, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $3,779.26 firm fixed-price delivery order is for the supply of GARDASIL 9 SYRINGE 0.5ML, a pharmaceutical product, to support various military treatment facilities and healthcare programs. The contract has an ultimate completion date of August 15, 2024 and is not designated as a set-aside. AmerisourceBergen, a major pharmaceutical distributor, has...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The contract, valued at $15,685.00, is for the delivery of GARDASIL 9 SYRINGE 0.5ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of September 18, 2024. This contract is not designated as a set-aside and is likely part of a larger Indefinite Delivery...
This federal contract award, valued at $14,757.05, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order for the supply of GARDASIL 9 SYRINGE 0.5ML, a critical vaccine product. The contract has a firm fixed price pricing type and an ultimate completion date of June 27, 2024. AmerisourceBergen, through its Corporate Office division, will deliver these medical supplies to support the DLA Troop Support...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,128.77 firm-fixed-price delivery order is for the supply of the GARDASIL 9 SYRINGE 0.5ML vaccine, a key immunization product for the military and other federal healthcare beneficiaries. The contract has an ultimate completion date of September 17, 2024 and does not utilize any set-aside provisions....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,695.26 Firm Fixed Price Delivery Order is for the procurement of GARDASIL 9 SYRINGE 0.5ML, a vaccine product. The contract has an ultimate completion date of February 18, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The award, valued at $6,017.19, is for the delivery of 4,565,361,369 units of the GARDASIL 9 vaccine syringe (0.5 mL) to support military treatment programs and facilities. The contract is a Delivery Order with a Firm Fixed Price pricing type. The Ultimate Completion Date is August 7, 2024. Amerisourcebergen, a major...